These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Anti-idiotypic activity in cytotoxic sera from highly sensitised patients (HSP) given cyclosporin A and blood transfusion from a specific donor (ST). al-Muzairai IA; MacLeod AM; Cochrane S; Jones MC; Propper D; Catto GR Transplant Proc; 1989 Feb; 21(1 Pt 1):748-9. PubMed ID: 2650254 [No Abstract] [Full Text] [Related]
5. Cyclosporine A, hyperimmunized patients, and renal retransplantation. Hendriks GF; de Lange P; Persijn GG; van Rood JJ Transplant Proc; 1987 Feb; 19(1 Pt 1):733-4. PubMed ID: 3274857 [No Abstract] [Full Text] [Related]
6. Influence of pretransplant antibodies on early renal allograft rejection. Alarif L; Rodriguez R; Blackburn S; Light JA Transplant Proc; 1987 Feb; 19(1 Pt 1):771-2. PubMed ID: 3274869 [No Abstract] [Full Text] [Related]
7. Positive B cell crossmatches in highly sensitized patients--influence of antibody specificity on renal transplant outcome. Lazda VA; Pollak R; Mozes MF; Jonasson O Transplant Proc; 1987 Feb; 19(1 Pt 1):782-4. PubMed ID: 3547840 [No Abstract] [Full Text] [Related]
8. Effects of HLA matching and panel reactive antibodies in the development of rejection after conversion of cyclosporine to azathioprine. Zemel SM; Shen SY; Weir MR; Dagher FJ; Bentley FR Transplant Proc; 1987 Feb; 19(1 Pt 3):2029-31. PubMed ID: 3274466 [No Abstract] [Full Text] [Related]
9. Renal allograft survival in CSA-treated patients with positive donor-specific B cell crossmatches. Noreen HJ; van der Hagen E; Bach FH; Najarian JS; Fryd DS Transplant Proc; 1989 Feb; 21(1 Pt 1):691-2. PubMed ID: 2650224 [No Abstract] [Full Text] [Related]
10. The impact of cyclosporine A on the DRw6 effect in renal transplantation. Hendriks GF; de Lange P; Schreuder GM; D'Amaro J; Persijn GG; van Rood JJ Transplant Proc; 1987 Feb; 19(1 Pt 1):650-1. PubMed ID: 3274832 [No Abstract] [Full Text] [Related]
11. Antiidiotypic antibody activity in patients receiving donor specific transfusions and cyclosporine A. Stewart KN; Power DA; Hills AN; Catto GR Transplant Proc; 1987 Feb; 19(1 Pt 3):2262-3. PubMed ID: 3079078 [No Abstract] [Full Text] [Related]
12. The results of renal transplantation with cyclosporine in immunologically high-risk patients. Dickerman RM; Vergne-Marini P; Langley J; Trevino G; Velez R; Brinker K; Nesser D; Long D; Hull AR Transplant Proc; 1987 Feb; 19(1 Pt 3):1846-8. PubMed ID: 3079047 [No Abstract] [Full Text] [Related]
13. A past positive crossmatch does not affect allograft survival for cyclosporine-immunosuppressed primary and secondary renal transplant recipients. Quinn T; Louis P; Mallis M; Senitzer DS; Tellis V; Matas A Transplant Proc; 1989 Feb; 21(1 Pt 1):704. PubMed ID: 2650232 [No Abstract] [Full Text] [Related]
14. Specific HLA antibody production following renal transplantation. Martin S; Dyer PA; Gokal R; Mallick NP; Johnson RW Transplant Proc; 1987 Feb; 19(1 Pt 1):898. PubMed ID: 3274885 [No Abstract] [Full Text] [Related]